Mia is a Partner in Oxeon Partners search business and has spent over 20 years working in the healthcare industry, holding commercial leadership roles in the pharmaceutical, medical technology, and executive search industries at companies such as Merck, Guidant, Boston Scientific, Russell Reynolds, and Oxeon. In her role at Oxeon, she partners with high growth, innovative healthcare organizations, boards, and investors to build diverse and cohesive leadership teams. Her projects include work with VC, Private Equity, and public company backed organizations across, payer, provider, consumer, employer, life sciences, and medical technology segments.
Throughout her career in the medical technology industry she spent her time leading exceptional teams and launching innovative products such as the industry’s first remote patient wireless platform and cardiac resynchronization therapy for heart failure patients throughout large provider systems in the United States and throughout Europe and Asia.
Mia combines her experience working within an innovative and disruptive organization while advising similarly oriented clients. Her experience with great teams, innovative technology and global sales and business development are utilized across Oxeon Holdings. Mia was attracted to Oxeon’s mission to help make people healthy as well as its rich culture. Mia cares deeply about health (her own and others) and if she is not found spending time with her family or twin sister’s family, she can be found at a 6am Barry’s Bootcamp class. Otherwise, the majority of her time is committed to helping innovative healthcare organizations find rockstar leaders. She currently lives in New York City (a short walk from the Oxeon office) with her husband Scott and two children, Nixon and Lexi.
Mia earned her undergraduate degree in Communications and Business at Villanova and has an MBA from Columbia and London Business School. At Columbia she served as the Co-Chair for Sanford Bernstein’s Ethics and Leadership program. She serves on the New York Academy of Medicine Board and as an Advisory Member of the The Moth’s Development Committee.